Pillstats
Rx only · Injection, Solution · Intravenous

Nicardipine Hydrochloride

Brands: Cardene Iv · Nicardipine Hydrochloride

9 ACTIVE SUPPLIERS — US
openFDA · updated weekly
US16 NDCs
9 active makers
UKComing
soon
CAComing
soon
AUComing
soon
EUComing
soon
RxCUI (US)7396
US makers9 labelers
Packages17
DEA / ScheduleNone

Medicaid dispensing volumeSDUD · per quarter

Prescriptions dispensed under Medicaid (fee-for-service + managed care), summed nationally. The closest free proxy to sales volume — Medicaid only, not all-payer.

1142293434582025 Q12025 Q22025 Q32025 Q42026 Q1
215
Rx · 2026 Q1
36K
Units dispensed
-46%
Rx vs. year ago
5
Quarters · since 2025 Q1

Who makes it9 active · 0 exited

US labelers as registered with FDA. Repackagers relabel another company's product; share* is of listed packages, not sales.

LabelerTypePackagesStatus
Baxter Healthcare Corporationunknown7SUPPLYING
WG Critical Care, LLCunknown2SUPPLYING
Eugia US LLCunknown2SUPPLYING
Qilu Pharmaceutical Co. Ltd.unknown1SUPPLYING
Sagent Pharmaceuticalsunknown1SUPPLYING
American Regent, Inc.unknown1SUPPLYING
Meitheal Pharmaceuticals Inc.unknown1SUPPLYING
Civica, Inc.unknown1SUPPLYING
Archis Pharma LLCunknown1SUPPLYING

Regulatory & supply eventsFDA · US

Shortages, recalls, and registration changes attached to this drug concept.

  • Apr 18, 2025
    RECALLRecall (Class II): niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, American Regent, In…

    Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. — Recalling firm: American Regent, Inc. — Nationwide in the USA

  • Apr 18, 2025
    RECALLRecall (Class II): niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 mL Single Dose Vial, Rx Only, Mfd for: Civica, In…

    Lack of sterility assurance: Product leakage around the vial neck, which could potentially result in a lack of sterility assurance. — Recalling firm: American Regent, Inc. — Nationwide in the USA

  • May 14, 2024
    RECALLRecall (Class II): niCARdipine Hydrochloride Injection, USP, 25 mg/10 mL (2.5 mg/mL), 10 x 10 mL Single Dose Vials, Rx Only, For Intraveno…

    Lack of Assurance of Sterility. — Recalling firm: American Regent, Inc. — UT only

  • Feb 20, 2024
    RECALLRecall (Class II): Nicardipine Hydrochloride Injection, USP 25mg/mL (2.5 mg/mL) 10 mL vials, Distributed by: AuroMedics Pharma LLC 279 Pri…

    Failed Impurities/Degradation Specifications: Out of specification for organic impurities — Recalling firm: Eugia US LLC — Nationwide within the United States

  • Feb 20, 2024
    RECALLRecall (Class II): Nicardipine Hydrochloride Injection (2.5mg/mL), US, 25mg per 10mL, 10mL Vial, Rx only, Distributed by: AuroMedics Phar…

    Failed Impurities/Degradation Specifications: Out of specification for organic impurities — Recalling firm: Eugia US LLC — Nationwide within the United States